AC
SGEN

Ascend Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Ascend Capital’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-164,648
Closed -$8.96M – 259
2017
Q3 		$8.96M Buy
+164,648
New +$8.43M 0.34% 85
2015
Q2 		– Sell
-140,000
Closed -$4.95M – 203
2015
Q1 		$4.95M Sell
140,000
-610,000
-81% -$20.8M 0.17% 114
2014
Q4 		$24.1M Buy
+750,000
New +$26.1M 0.92% 40

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ascend Capital's SGEN Position: Q4 2017 in Review

Ascend Capital sold out of Seagen Inc. Common Stock (SGEN) in Q4 2017, closing a stake of 164,648 shares — an estimated $8.96M sold.

Ascend Capital first reported a position in SGEN in Q4 2014 and held it in 3 quarters. The position peaked at $24.1M in Q4 2014. 298 funds tracked by Wall St. Rank hold SGEN as of Q4 2017.

  • Ascend Capital reported no remaining Seagen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Ascend Capital sold 164,648 Seagen Inc. Common Stock shares in Q4 2017, an estimated $8.96M.
  • Ascend Capital first reported a position in Seagen Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • Ascend Capital's Seagen Inc. Common Stock position peaked at $24.1M in Q4 2014.
  • 298 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2017.

Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.